Sun Pharmaceutical Industries Limited (SUNPHARMA) — Announcement Announcement
📢 Key Event
Sun Pharma schedules analyst/investor meetings for May 27, 2026
💡 Investor Takeaway
Investors should note no material updates will be shared at these meetings.
Sun Pharmaceutical announced its upcoming analyst and institutional investor meeting schedule on May 27, 2026, at the 360 ONE Capital 16th Annual Investor Conference in Mumbai, confirming no UPSI will be disclosed during these sessions.
📄 View Original Announcement (PDF)
About Sun Pharmaceutical Industries Limited (SUNPHARMA)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹4,50,643.09 Cr
P/E: 41.3
ROE: 15.1%
ROCE: 20.3%
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.